Avoid Transvenous Leads in Appropriate Subjects

See also
Status	Clinical Trial	Phase
Completed	`NCT02104583` - Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator	Phase 2
Active, not recruiting	`NCT01281241` - Study on Mechanical and Electrical Alternans	N/A
Completed	`NCT00993382` - Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death	Phase 2
Completed	`NCT00000504` - Cardiac Arrhythmia Pilot Study (CAPS)	Phase 2
Recruiting	`NCT06048731` - Enlighten Study: The EV-ICD Post Approval Registry
Terminated	`NCT02114528` - Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention	Phase 4
Completed	`NCT05099289` - Parasternal Access for ShockS and Pacing With an acUtely Placed Less-invasive Lead for EV-ICD (PASS PULL EV-ICD) Study	N/A
Completed	`NCT05352776` - Sensing and Defibrillation With a Commercially Available ICD Coupled With a Parasternal Extravascular Lead (SECURE EV) Study	N/A
Recruiting	`NCT01999140` - Implantable Cardioverter Defibrillator (ICD Registry)
Completed	`NCT02088619` - Positive Therapy for Autonomic Function & Mood in ICD Patients	N/A
Completed	`NCT00064558` - Genetic Determinants of Sudden Cardiac Death
Completed	`NCT00000518` - Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)	Phase 3
Completed	`NCT00102180` - Drug-Induced Sudden Death & Ventricular Arrhythmia
Completed	`NCT00006501` - Prognostic Significance of T Wave Alternans	N/A
Completed	`NCT01804439` - Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes	N/A
Completed	`NCT00000540` - Coronary Artery Bypass Graft (CABG) Patch Trial	Phase 3
Completed	`NCT00005235` - Heart Rate Variability and Sudden Cardiac Death	N/A
Completed	`NCT00005197` - Predictors of Perioperative Cardiac Morbidity	N/A
Enrolling by invitation	`NCT04520347` - IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
Completed	`NCT00000526` - Cardiac Arrhythmia Suppression Trial (CAST)	Phase 3

NCT number	NCT02881255
Study type	Interventional
Source	Population Health Research Institute
Contact
Status	Completed
Phase	N/A
Start date	February 22, 2017
Completion date	February 10, 2022

Avoid Transvenous Leads in Appropriate Subjects — ATLAS S-ICD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms